Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 4.94M P/E - EPS this Y - Ern Qtrly Grth -
Income -5.08M Forward P/E -0.76 EPS next Y - 50D Avg Chg -9.00%
Sales 12.31M PEG - EPS past 5Y - 200D Avg Chg -23.00%
Dividend N/A Price/Book 0.62 EPS next 5Y - 52W High Chg -73.00%
Recommedations 1.00 Quick Ratio 1.80 Shares Outstanding 15.61M 52W Low Chg 32.00%
Insider Own 1.56% ROA -19.44% Shares Float 15.35M Beta 1.29
Inst Own 1.95% ROE -82.87% Shares Shorted/Prior 30.35K/121.45K Price 1.00
Gross Margin 36.70% Profit Margin -41.24% Avg. Volume 530,661 Target Price -
Oper. Margin -26.90% Earnings Date Jun 19 Volume 73,169 Change -8.26%
About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, Asia, and internationally. The company offers Regenacyn, a prescription scar gel; Pediacyn, a pediatric dermatology and wound care product for over-the-counter (OTC) use; Epicyn, an Antimicrobial Facial Cleanser; Levicyn, an HOCl based prescription and OTC product to use and relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Gramaderm for the treatment of topical mild to moderate acne; Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens; Ocucyn eyelid and eyelash cleanser; Microdacyn60 oral care solution for the treatment of mouth and throat infections; and Podiacyn, a foot care product. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; MicrocynVS, a veterinarian-strength animal care product used in vet clinics and animal hospitals; Nanocyn, a hospital-grade disinfectant; Acuicyn, an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.

Sonoma Pharmaceuticals, Inc. News
04/09/24 Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
04/04/24 Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
03/28/24 Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences
03/27/24 Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals
02/10/24 Sonoma Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
02/08/24 Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
01/23/24 Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use
01/09/24 NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
11/13/23 Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results
11/03/23 Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference
10/26/23 Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock
09/21/23 Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
08/15/23 National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
08/10/23 Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results
08/03/23 Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board
06/22/23 Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results
06/08/23 Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union
04/19/23 Benign Growth For Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Underpins Its Share Price
SNOA Chatroom

User Image GillyBibbons Posted - 12 hours ago

$SNOA

User Image ButterCapital Posted - 2 days ago

$SNOA added some

User Image Manipulation13F Posted - 2 days ago

$SNOA New support here could see a possible run up

User Image colmillos_blancos Posted - 6 days ago

$SNOA I think that tomorrow many will run after her

User Image colmillos_blancos Posted - 1 week ago

$SNOA sonoma pharmaceutical breaking m200 closure news

User Image RollingDollar Posted - 1 week ago

$SNOA

User Image PapaRoki Posted - 1 week ago

$SNOA getting saucy

User Image colmillos_blancos Posted - 1 week ago

$SNOA fda removes benzene from market that is duplicating and it already does it for fear of cancer when using it Sonoma and its products growing due to social alert find out that it is not news, there is a lot of news

User Image colmillos_blancos Posted - 1 week ago

$SNOA You are a liar, where they marketed that product, it is totally new. It shows that you are positioned downwards so be alert that there is a merger very soon and money

User Image MicroTrader69 Posted - 1 week ago

$SNOA this company puts out a press release, “releasing” a product in the same sizes they have offered in their Negative Pressure Wound Therapy solution for 10+ years…. Nothing new here. They are trying to fool all of you!

User Image RollingDollar Posted - 1 week ago

$SNOA

User Image colmillos_blancos Posted - 1 week ago

$SNOA sales forecast to multiply by 5 spectacular dollar

User Image RollingDollar Posted - 1 week ago

$SNOA .

User Image colmillos_blancos Posted - 1 week ago

$SNOA News in sonoma pharmaceuticals. It will explode very soon

User Image NYPD Posted - 1 week ago

$SNOA another good news and 2.3 Mio $ marketcap.....

User Image Stock_Titan Posted - 1 week ago

$SNOA Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States https://www.stocktitan.net/news/SNOA/sonoma-pharmaceuticals-announces-expansion-of-negative-pressure-ah83qgygnwx1.html

User Image GermanBulle Posted - 1 week ago

$NBY Red Red Red . A lot of selling. In my opinion. Whoever controls this, wants 2 DESTROY this company or knows something retails don’t know. Good luck poor investors! Crazy stock Also $BIMI $SNOA

User Image Stock_Titan Posted - 1 week ago

$SNOA Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections https://www.stocktitan.net/news/SNOA/sonoma-pharmaceuticals-reports-recent-publication-from-australia-d20slss5d0m8.html

User Image colmillos_blancos Posted - 2 weeks ago

$SNOA the sonoma news the mo market gives it enough value hospital product distribution agreements and now benzene has its bad reputation sonoma sales increase should be trading above 0.25

User Image Trident1014 Posted - 2 weeks ago

$SNOA Hello?

User Image colmillos_blancos Posted - 2 weeks ago

$SNOA According to an independent laboratory, highly carcinogenic benzene has been discovered in topical use represented in leading brands. The FDA will imminently prohibit the marketing of these topical products starting today.

User Image MicroTrader69 Posted - 2 weeks ago

$SNOA

User Image colmillos_blancos Posted - 2 weeks ago

$SNOA I think that between today and tomorrow I should attack 0.20

User Image DSTOCK80 Posted - 2 weeks ago

$SNOA .16 🔥🔥🔥

User Image PapaRoki Posted - 03/31/24

$SNOA wick fill coming

User Image irrational_actor Posted - 03/30/24

$SNOA $DARE $LENZ $CERO This short sell mafia scammer author "can't name a squeeze" will get REKT and suffer a market death monday.

User Image MicroTrader69 Posted - 03/30/24

@GermanBulle $SNOA doesn’t have the money to buy anything. They only have money to give Bruce & Amy(COO & CEO) raises year over year. They have operated at a loss for years. They are trying to sell the company and no-one wants it😂

User Image CantNameThatTune Posted - 03/30/24

$CERO 201 Haskins Way is CERO's home. It's also where several other fledgling startup biotechs call home. $GRPH came to market in 2021 on the promise of a cure for sickle cell anemia. Their trials quickly flopped and they just reverse merged with $LENZ last week. They paid $58 million to break their lease at 201 Haskins Way. This is also where Sonoma Biotherapeutics resides. Their T reg platform has garnered $365 million in funding but still not public. Remember, CERO comes to market with $13 mil in cash. Not to be confused with $SNOA that I told you 5 yrs ago would die because a woman, an attorney, was running it. Same with $DARE. Both scam stocks. Eli Lilly calls 201 Haskins Way home to their Gateway Labs where 15 biotechs all share scientists and equipment as an incubator for Lilly. It's been 4 years and Lilly hasn't done a thing for CERO with their cure for Leukemia. The CEO of Lilly states it is 10-15 yrs for preclinical to get to market.

User Image Stock_Titan Posted - 03/28/24

$SNOA Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences https://www.stocktitan.net/news/SNOA/sonoma-pharmaceuticals-to-present-at-trickle-research-and-ld-micro-jlc1ihyfvf1t.html

User Image Pete1244 Posted - 03/28/24

$SNOA

Analyst Ratings
Ladenburg Thalmann Buy Sep 5, 23
Maxim Group Hold Mar 6, 18
Benchmark Speculative Buy Dec 28, 17
Maxim Group Buy Nov 10, 17